Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population
暂无分享,去创建一个
Beverley Balkau | Amalia Gastaldelli | B. Balkau | M. Kozáková | A. Gastaldelli | K. Højlund | A. Flyvbjerg | A. Mitrakou | Kurt Højlund | Allan Flyvbjerg | Michaela Kozakova | Angela Favuzzi | Asimina Mitrakou | A. Favuzzi | M. Kozàkovà
[1] G. Marchesini,et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease , 2005, Hepatology.
[2] G. Zoppini,et al. Non‐alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non‐diabetic men. Role of visceral adipose tissue , 2005, Diabetic medicine : a journal of the British Diabetic Association.
[3] R. Kronmal,et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. , 1999, The New England journal of medicine.
[4] G. Marchesini,et al. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. , 2005, The Journal of clinical endocrinology and metabolism.
[5] A. Kotronen,et al. Fatty Liver: A Novel Component of the Metabolic Syndrome , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[6] J. Tuomilehto,et al. Epidemiological studies of exercise in diabetes prevention. , 2007, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.
[7] Jeanne M Clark,et al. The Epidemiology of Nonalcoholic Fatty Liver Disease in Adults , 2006, Journal of clinical gastroenterology.
[8] Anson,et al. DIET , LIFESTYLE , AND THE RISK OF TYPE 2 DIABETES MELLITUS IN WOMEN , 2001 .
[9] Jeanne M Clark,et al. Weight Loss as a Treatment for Nonalcoholic Fatty Liver Disease , 2006, Journal of clinical gastroenterology.
[10] D. Lawlor,et al. The associations of physical activity and adiposity with alanine aminotransferase and gamma-glutamyltransferase. , 2005, American journal of epidemiology.
[11] J. Everhart,et al. Epidemiology of nonalcoholic fatty liver. , 2004, Clinics in liver disease.
[12] U. John,et al. Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. , 2005, World journal of gastroenterology.
[13] P S Freedson,et al. Calibration of the Computer Science and Applications, Inc. accelerometer. , 1998, Medicine and science in sports and exercise.
[14] S M Grundy,et al. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. , 1998, Circulation.
[15] G. Zoppini,et al. Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled Type 2 diabetic patients , 2006, Journal of endocrinological investigation.
[16] S. Sanderson,et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.
[17] G. Targher,et al. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. , 2007, Atherosclerosis.
[18] L. Bouter,et al. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. , 2007, Atherosclerosis.
[19] H. Parving,et al. Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications , 2005, Diabetologia.
[20] Anna Castiglione,et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population , 2006, BMC gastroenterology.
[21] Albert Hofman,et al. Increased common carotid intima-media thickness. Adaptive response or a reflection of atherosclerosis? Findings from the Rotterdam Study. , 1997, Stroke.
[22] M. Walker,et al. Insulin resistance, insulin response, and obesity as indicators of metabolic risk. , 2007, The Journal of clinical endocrinology and metabolism.
[23] S. Kihara,et al. Adiponectin, hepatocellular dysfunction and insulin sensitivity , 2004, Clinical endocrinology.
[24] Eary,et al. CAROTID-ARTERY INTIMA AND MEDIA THICKNESS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND STROKE IN OLDER ADULTS , 2000 .
[25] Emilio Ros,et al. Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis: A Case–Control Study , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[26] D. Grobbee,et al. Carotid artery intima‐media thickness as an indicator of generalized atherosclerosis , 1994, Journal of internal medicine.
[27] M. Walker,et al. The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and Objectives , 2004, Diabetologia.
[28] D L Rothman,et al. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. , 1996, The New England journal of medicine.
[29] O. Kocaman,et al. Evaluation of Metabolic Syndrome Frequency and Carotid Artery Intima-media Thickness as Risk Factors for Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease , 2008, Digestive Diseases and Sciences.